
Associate Professor, MD Anderson Cancer Center. We are dedicated to identifying novel therapies for lung and pancreatic cancer. Join our team! #mazurforthecure
Houston, TX
Joined July 2009
- Tweets241
- Following222
- Followers394
- Likes83
Pawel K. Mazur retweeted
The MazurLab @MDAndersonNews was walking at the #PanCANPurpleStride #PurpleStrideHouston today to raise awareness for this devastating disease and show support for pancreatic cancer survivors @PanCAN @PancanHouston
Pawel K. Mazur retweeted
The @MazurLab met early this morning to support pancreatic cancer research at #PanCANPurpleStride in Houston
Pawel K. Mazur retweeted
Excited about this publication from star student Andrea Chaikovsky @stanfordcbio on the regulation of Cyclin D levels and the response to Cdk4/6 inhibitors. Close collaboration with many labs, including @LabWinslow, @PetrovADmitri, @cncurtis, @KroganLab... rdcu.be/ciGW3
Pawel K. Mazur retweeted
#ResearchWatch: The histone methyltransferase NSD3 is a lung squamous cell carcinoma driver.
@MazurLab @MDAndersonNews @Stanford #LungCancer #Epigenetics
bit.ly/3qxsTov
Pawel K. Mazur retweeted
NEW #ResearchHighlight! Research by the teams of Shao, Jaremko, Mazur @MazurLab & Gozani shows that NSD3, which encodes a histone H3 lysine 36 methyltransferase, is likely an important driver of a subset of lung squamous cell carcinomas. 📯 go.nature.com/3qMIgcJ
@NatResCancer
Pawel K. Mazur retweeted
New work from Or Gozani @MazurLab and co. finds that a mutated form of NSD3 results in increased H3K36 methylation and promotes lung cancer development. Also used EpiCypher's pAG-MNase for CUT&RUN assays and our nucleosomes for HMT experiments! #chromatin
nature.com/articles/s41586-0…
Pawel K. Mazur retweeted
Trending on PubMed: Elevated NSD3 histone methylation activity drives squamous cell lung cancer. pubmed.ncbi.nlm.nih.gov/3353…
Pawel K. Mazur retweeted
Elevated NSD3 histone methylation activity drives squamous cell lung cancer | Nature nature.com/articles/s41586-0…
Pawel K. Mazur retweeted
Hyperactivity of the methyltransferase protein NSD3 drives some cancers go.nature.com/3rd90Tw
Pawel K. Mazur retweeted
Researchers at @Stanford, @MDAndersonNews, @KAUST_News & @UM_1981 showed that elevated NSD3 histone methylation activity drives squamous cell #LungCancer.
📌 @nature
🔗 go.nature.com/3oKFNgV
Pawel K. Mazur retweeted
The discovery that methyltransferase protein NSD3 drives some cancers opens up new therapeutic opportunities go.nature.com/3rd90Tw
Pawel K. Mazur retweeted
Hyperactivity of the methyltransferase protein NSD3 drives some cancers go.nature.com/3rd90Tw
Pawel K. Mazur retweeted
SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy dlvr.it/RYJZSK
Pawel K. Mazur retweeted
Scientists from @MDAndersonNews identify SETD5 as a major driver of pancreatic ductal adenocarcinoma resistance to MEK1/2 inhibition.
Published in @Cancer_Cell: bit.ly/2Utug9v
Pawel K. Mazur retweeted
Congratulations to @MazurLab and collaborators, including the Gozani lab, for their beautiful work on Setd5 and resistance to treatment in pancreatic cancer. Excited to finally publish with @Aiims1742! sciencedirect.com/science/ar…
Pawel K. Mazur retweeted
I'm pretty tired of hearing how we scientists are supposed to be so productive now. Anyone with kids, elderly parents, lab members to worry about, stranded masters students, etc is too stressed and busy to be thinking big thoughts.
Pawel K. Mazur retweeted
Lots of good news, including in lung cancer in general, but still a flat survival for SCLC sadly
Excited to have @NCIDirector Ned Sharpless with us today. Looking forward to his talk, thanks @SCIDirector for inviting him!
Pawel K. Mazur retweeted
SCI member Crystal Mackall and colleagues modified #CARTcells to remain active in mice even under conditions that would normally result in their exhaustion - important implications for developing the next generation of #cancer #immunotherapy treatments. stan.md/2PjONKy
Pawel K. Mazur retweeted
Excited to share our review with @TuomasTammela, who is a true master of both tumor heterogeneity and mouse models @AnnualReviews annualreviews.org/doi/abs/10…
Pawel K. Mazur retweeted
Doug Hanahan in @PNASNews on deregulated MicroRNAs in pancreatic #Neuroendocrine tumors. A new algorithm (Bio-miRTa) is described for identifying functionally relevant gene targets of MicroRNAs.
pnas.org/content/early/2019/…






























